To achieve therapeutic cardiac regeneration, the University of Washington Medicine Heart Regeneration Program has been focusing on remuscularization with genuine cardiomyocytes derived from pluripotent stem-cells.
Dr. Nakamura presented his work during the 2023 Society of Toxicology (SOT) conference in Nashville.
This article summarizes some of the key points that were presented during the event and includes the video recording of the talk.
Dr. Nakamura is Director of Preclinical Research at the UW Medicine Heart Regeneration Program. This translational research focuses on pluripotent stem cell-based cardiac remuscularization therapies using various preclinical models to optimize the efficacy, safety, engraftment and maturation of cardiomyocyte transplantation through novel genetic, metabolic, immunomodulatory, antiarrhythmic and delivery strategies.
Dr. Nakamura obtained his medical degree at the University of California, San Francisco and clinical training at the Massachusetts General Hospital/Harvard Medical School with post-doctoral studies at the Massachusetts Institute of Technology. He is an Assistant Professor of Medicine at the University of Washington and directs the Cardiac Catheterization Laboratory at the VA Puget Sound Healthcare System.
